Cow's Milk Protein Allergy
Key points
- Definition: a reproducible immune-mediated reaction to cow's milk proteins - principally casein, beta-lactoglobulin and alpha-lactalbumin. It is not the same as lactose intolerance.
- How common: the commonest food allergy of infancy, affecting around 2-3% of infants in the first year of life.
- Two mechanisms: IgE-mediated reactions occur within minutes to 2 hours; non-IgE-mediated reactions take 2-72 hours and are dominated by gastrointestinal and skin symptoms.
- Breastfed infants are not exempt: cow's milk protein from the maternal diet passes into breast milk and can produce symptoms in an exclusively breastfed baby.
- Diagnosis: an allergy-focused history first. Skin prick testing and specific IgE help only in IgE-mediated disease; there is no test for non-IgE disease.
- The diagnostic manoeuvre: elimination of cow's milk protein for 2-4 weeks followed by planned reintroduction. Symptoms must both settle and return for the diagnosis to be secure.
- Formula: extensively hydrolysed formula first line, and amino acid formula for severe disease, faltering growth, anaphylaxis or symptoms while exclusively breastfed.
- Prognosis: excellent. Around three-quarters of children tolerate milk by 3 years and over 90% by school age, reintroduced using the milk ladder.
Introduction
Cow's milk protein allergy (CMPA) is an immune-mediated adverse reaction to one or more of the proteins in cow's milk. It is the commonest food allergy of infancy and one of the commonest reasons a young baby is referred with vomiting, unsettledness or blood in the stool.
It is also one of the most over-diagnosed conditions in primary care. Specialist formula prescribing in the UK has risen far faster than any plausible increase in prevalence, and a large number of infants are placed on restricted diets without the elimination-and-reintroduction step that would confirm or refute the diagnosis. Getting this right matters in both directions: a missed diagnosis leaves an infant in pain and failing to grow, and an over-diagnosis commits a family to an expensive, restrictive diet for a problem the child never had.
The first distinction to make is with lactose intolerance, which is not an allergy at all but a deficiency of the brush-border enzyme lactase. In infancy it is almost always secondary and transient - typically following a gastroenteritis that has stripped the intestinal villi - and it causes osmotic diarrhoea, wind and perianal excoriation without any immune involvement, blood in the stool or skin manifestations.
Classification and pathophysiology
| IgE-mediated | Non-IgE-mediated | |
|---|---|---|
| Mechanism | Type I hypersensitivity - specific IgE on mast cells and basophils triggers immediate degranulation | T-cell mediated delayed hypersensitivity affecting the gut mucosa and skin |
| Timing after ingestion | Minutes to 2 hours | 2 to 72 hours, occasionally up to a week |
| Skin | Acute urticaria, angio-oedema, flushing, pruritus | Atopic eczema, often treatment-resistant, and pruritus |
| Gastrointestinal | Immediate vomiting, colicky pain, oral pruritus | Reflux, food refusal, colic, loose or frequent stools, constipation, blood or mucus in the stool, perianal redness, faltering growth |
| Respiratory | Cough, wheeze, stridor, rhinitis - usually with skin or gut features | Rarely involved |
| Severe form | Anaphylaxis with cardiovascular or respiratory compromise | FPIES - profuse repetitive vomiting, pallor, lethargy and shock 1-4 hours after ingestion |
| Diagnostic testing | Skin prick test and specific IgE, interpreted alongside the history | No test exists. Diagnosis rests on elimination and reintroduction. |
| Typical age at resolution | Later - a minority persist into adolescence | Earlier - most tolerate milk between 1 and 3 years |
Mixed presentations occur, and it is entirely possible for an infant to have immediate urticaria with milk as well as chronic eczema and loose stools. What matters clinically is whether there is any IgE-mediated component, because that determines the risk of anaphylaxis and therefore how reintroduction is managed.
Risk factors and clinical assessment
Risk factors
- A personal history of atopy, particularly early-onset or severe atopic eczema
- A family history of atopy in a parent or sibling - eczema, asthma, allergic rhinitis or food allergy
- Formula feeding, or the introduction of formula top-ups
- Delivery by caesarean section, associated with altered early gut colonisation
The allergy-focused clinical history
NICE CG116 makes this the foundation of diagnosis, and in non-IgE disease it is essentially all there is.1 Cover:
- What the symptoms are, and in which systems - skin, gut and respiratory
- How long after the feed they appear, which separates IgE from non-IgE mechanisms
- Reproducibility - do the same symptoms follow the same exposure every time?
- Feeding history - breast, formula, brand, volumes, when formula was introduced, and what the mother is eating if breastfeeding
- Growth, plotted on the chart, since faltering growth changes the choice of formula
- Personal and family atopy
- What has already been tried, including any elimination diet and whether symptoms improved
- Impact on the family - sleep, feeding, distress and parental anxiety
Examination
- Plot weight, length and head circumference on the growth chart, and look at the trajectory rather than a single point
- Skin - eczema, its distribution and severity, urticaria, and evidence of scratching
- Abdomen - distension, tenderness, palpable faecal loading
- Perianal area - excoriation and erythema, seen in both CMPA and lactose intolerance
- Signs of an alternative diagnosis - dysmorphism, hepatosplenomegaly, respiratory signs, or evidence of a systemic illness
- Hydration and general wellbeing
Investigations
- Skin prick testing and serum specific IgE - useful only for IgE-mediated disease. A positive result indicates sensitisation, not allergy: it must be interpreted alongside a compatible history, since many sensitised children eat milk without any reaction.
- Elimination and reintroduction - the diagnostic test for non-IgE disease. Exclude cow's milk protein for 2-4 weeks (up to 6 weeks where symptoms are gut-predominant), assess whether symptoms resolve, then reintroduce to see whether they return. Both halves are required; an improvement alone is not diagnostic, because many infantile symptoms settle with time anyway.
- Double-blind placebo-controlled food challenge - the gold standard, reserved for diagnostic uncertainty or where the stakes are high, and performed in a specialist setting
- FBC and ferritin where there is blood loss in the stool or pallor, looking for iron deficiency anaemia
- Coeliac serology, faecal calprotectin, stool culture and a sweat test where the picture suggests an alternative diagnosis
Differential diagnosis
| Condition | Distinguishing features |
|---|---|
| Lactose intolerance | Enzyme deficiency, not immune. Watery explosive stools, wind, perianal excoriation. No blood in stool, no eczema, no urticaria. Usually secondary to gastroenteritis and transient. |
| Gastro-oesophageal reflux | Effortless posseting in a thriving infant, no other system involved. Note that reflux is also a feature of non-IgE CMPA, and the two are often difficult to separate.6 |
| Infantile colic | Rule of threes - crying over 3 hours a day, more than 3 days a week; otherwise well and thriving, resolves by 4-5 months |
| Anal fissure | Fresh blood streaking the outside of a hard stool in a constipated infant, visible on inspection |
| Gastroenteritis | Acute onset, contact history, diarrhoea and vomiting settling over days |
| Coeliac disease | Appears after gluten introduction at weaning, with faltering growth, diarrhoea, abdominal distension and irritability |
| Other food allergy | Egg, soya, wheat, peanut - the history identifies the trigger |
| Eosinophilic oesophagitis | Older child, dysphagia and food impaction, diagnosed on endoscopic biopsy |
| Faltering growth from inadequate intake | Feeding assessment shows insufficient volume or ineffective feeding rather than an allergic reaction |
Management
The breastfed infant
- Continue breastfeeding - this is never a reason to stop, and stopping removes the infant's best source of nutrition and immune protection
- Exclude all cow's milk protein from the maternal diet - milk, cheese, butter, yoghurt, cream and hidden sources in processed food - for a trial of 2-4 weeks
- Supplement the mother with calcium 1000 mg daily and vitamin D 10 micrograms daily, since a dairy-free diet is otherwise calcium-deficient
- Refer to a paediatric dietitian, which is essential rather than optional in this situation
- Reintroduce cow's milk protein into the maternal diet after the trial to confirm the diagnosis
The formula-fed infant
| Formula | When to use | Notes |
|---|---|---|
| Extensively hydrolysed formula (eHF) | First line for most infants with mild to moderate CMPA | Proteins are broken into peptides too small for most infants to react to; tolerated by around 90%. Taste is unpleasant and acceptance may take 1-2 weeks. |
| Amino acid formula (AAF) | Severe symptoms, faltering growth, anaphylaxis, FPIES or severe enteropathy, symptoms while exclusively breastfed, or failure of an extensively hydrolysed formula | Contains no intact protein or peptides at all. More expensive, so reserved for these indications. |
| Soya formula | Not under 6 months | Phyto-oestrogen content, and cross-reactivity in 10-15% of infants with CMPA - particularly those with non-IgE disease |
| Goat, sheep or other mammalian milks | Never | Extensive cross-reactivity with cow's milk protein - these are not a safe alternative |
| Partially hydrolysed formula | Never for treatment | Retains enough intact protein to provoke reactions; it is a preventive product, not a therapeutic one |
| Rice, oat, almond and other plant drinks | Not as a main milk under 1 year | Nutritionally inadequate; rice drinks are additionally unsuitable under 4.5 years because of arsenic content |
Wider management
- Dietitian referral for every child, to ensure adequate calcium, vitamin D, protein and energy intake and to guide weaning
- A written management plan, including what to avoid and how to read food labels
- Treat the eczema properly with emollients and topical corticosteroids - dietary exclusion alone rarely controls it6
- An adrenaline auto-injector for any child with IgE-mediated allergy who has had anaphylaxis, or who has a significant reaction plus coexisting asthma, with training for the family and a plan for nursery or school7,8
- Specialist allergy referral for anaphylaxis, faltering growth, multiple food allergies, severe eczema, or diagnostic uncertainty4
- Regular growth monitoring, since both the allergy and the diet used to treat it can impair growth
Reintroduction and the milk ladder
Most infants outgrow CMPA, so the plan from the point of diagnosis should include when and how milk will be tried again. Leaving a child on a hypoallergenic formula indefinitely, without a reintroduction plan, is a common and avoidable failing.
For non-IgE-mediated allergy, reintroduction is usually attempted at home from around 9-12 months of age, and at least 6 months after diagnosis, using the iMAP milk ladder.3,5 The ladder works because heating denatures the conformational epitopes on milk proteins, so baked milk is far less allergenic than fresh milk. Each step is maintained for several days before moving up.
- Malted milk biscuit - milk baked at high temperature within a wheat matrix, the least allergenic form
- Muffin or cake containing milk
- Pancake
- Cheese, cooked as in a pizza topping
- Yoghurt or fromage frais
- Pasteurised cow's milk and fresh dairy products
Complications and prognosis
Complications
- Faltering growth, from the allergy itself, from feed refusal, or from an over-restricted replacement diet
- Nutritional deficiency - calcium, vitamin D, iodine, protein and energy in particular
- Iron deficiency anaemia from chronic occult blood loss in allergic proctocolitis
- Anaphylaxis in IgE-mediated disease
- Over-diagnosis and unnecessary dietary restriction, with cost, social burden and food-related anxiety - a genuine harm, and increasingly recognised as such
- Feeding aversion and later fussy eating, particularly where many foods have been excluded
- Eosinophilic oesophagitis in a small number, presenting later with dysphagia
Prognosis
The outlook is very good. Around half of infants with non-IgE-mediated CMPA tolerate milk by their first birthday, roughly three-quarters by 3 years, and more than 90% by school age.2,3 IgE-mediated allergy resolves more slowly, and a minority - typically those with high and persistently rising specific IgE levels, multiple food allergies and severe atopy - continue to react into adolescence and adult life.
Families should be told at diagnosis roughly what to expect: that this is common, that it is not the same as being allergic to milk for life, that the great majority of children are drinking ordinary milk before they start school, and that there will be a planned attempt to reintroduce it rather than an indefinite avoidance. That framing reduces a great deal of anxiety and makes families far more willing to attempt the ladder when the time comes.
Two things predict a good outcome and are within a clinician's control: making the diagnosis properly in the first place, with a documented elimination and reintroduction rather than an assumption; and building the reintroduction plan into the management from the outset, so that the child is challenged at the right time rather than remaining on a specialist formula because nobody revisited it.
References
- NICE CG116. Food allergy in under 19s: assessment and diagnosis. 2011. Available here
- NICE Clinical Knowledge Summaries. Cow's milk allergy in children. Available here
- Venter C, Brown T, Meyer R et al. Better recognition, diagnosis and management of non-IgE-mediated cow's milk allergy in infancy: iMAP - an international interpretation of the MAP guideline. Clinical and Translational Allergy. 2017. Available here
- NICE QS118. Food allergy quality standard. 2016. Available here
- GP Infant Feeding Network. The iMAP milk ladder and supporting resources. Available here
- NICE Clinical Knowledge Summaries. Eczema - atopic. Available here
- Resuscitation Council UK. Emergency treatment of anaphylaxis: guidelines. Available here
- NICE CG134. Anaphylaxis: assessment and referral after emergency treatment. 2011, updated 2020. Available here
This article is written for revision and education. It is not clinical guidance and must not be used to make decisions about the care of a patient. Always check current NICE guidance and local protocols.